Paper36719907
Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.
Turtle L and 19 others. PLoS Med, 2023. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study. Papers, record 36719907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36719907
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Male | |
| Humans | |
| Female | |
| Middle Aged | |
| Aged | |
| SARS-CoV-2 | |
| Prospective Studies | |
| Hospital Mortality | |
| Bayes Theorem | |
| Immunocompromised Host | |
| United Kingdom | |
| World Health Organization |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 205228/Z/16/Z | Wellcome Trust | United Kingdom | PubMed | |
| 205228/Z/16/Z | Wellcome Trust | United Kingdom | PubMed | |
| MC_PC_20058 | Medical Research Council | United Kingdom | PubMed | |
| MR/V028979/1 | Medical Research Council | United Kingdom | PubMed | |
| MC_PC_19026 | Medical Research Council | United Kingdom | PubMed | |
| MC_PC_19059 | Medical Research Council | United Kingdom | PubMed | |
| 200927 | Department of Health | United Kingdom | PubMed | |
| MC_PC_19025 | Medical Research Council | United Kingdom | PubMed | |
| 215091/Z/18/Z | Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34806036 | Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative. | Lancet Rheumatol | 2022 | https://conductscience.org/library/papers/34806036 | PubMed |
| 2 | 33217246 | Tissue-Specific Immunopathology in Fatal COVID-19. | Am J Respir Crit Care Med | 2021 | https://conductscience.org/library/papers/33217246 | PubMed |
| 3 | 36209762 | WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed. | Lancet | 2022 | https://conductscience.org/library/papers/36209762 | PubMed |
| 4 | 35178709 | Hospital admission for symptomatic COVID-19 and impact of vaccination: analysis of linked data from the Coronavirus Clinical Information Network and the National Immunisation Management Service. | Anaesthesia | 2022 | https://conductscience.org/library/papers/35178709 | PubMed |
| 5 | 33275763 | Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. | Nephrol Dial Transplant | 2020 | https://conductscience.org/library/papers/33275763 | PubMed |
| 6 | 32640463 | Factors associated with COVID-19-related death using OpenSAFELY. | Nature | 2020 | https://conductscience.org/library/papers/32640463 | PubMed |
| 7 | 32669287 | Comprehensive mapping of immune perturbations associated with severe COVID-19. | Sci Immunol | 2020 | https://conductscience.org/library/papers/32669287 | PubMed |
| 8 | 33069762 | COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. | Kidney Int | 2020 | https://conductscience.org/library/papers/33069762 | PubMed |
| 9 | 35449394 | Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves. | Pediatr Res | 2023 | https://conductscience.org/library/papers/35449394 | PubMed |
| 10 | 28645171 | UpSetR: an R package for the visualization of intersecting sets and their properties. | Bioinformatics | 2017 | https://conductscience.org/library/papers/28645171 | PubMed |
| 11 | 34096966 | Vaccinated but Not Protected-Living Immunocompromised During the Pandemic. | JAMA | 2021 | https://conductscience.org/library/papers/34096966 | PubMed |
| 12 | 33692097 | Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. | Sci Immunol | 2021 | https://conductscience.org/library/papers/33692097 | PubMed |
| 13 | 34142653 | Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. | Euro Surveill | 2021 | https://conductscience.org/library/papers/34142653 | PubMed |
| 14 | 33631065 | Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33631065 | PubMed |
| 15 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 16 | 33259686 | Is COVID-19 infection more severe in kidney transplant recipients? | Am J Transplant | 2021 | https://conductscience.org/library/papers/33259686 | PubMed |
| 17 | 33979301 | High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33979301 | PubMed |
| 18 | 34075212 | SARS-CoV-2 variants, spike mutations and immune escape. | Nat Rev Microbiol | 2021 | https://conductscience.org/library/papers/34075212 | PubMed |
| 19 | 35176230 | Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/35176230 | PubMed |
| 20 | 35503007 | The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35503007 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787905 | Describing a Persistent SARS-CoV-2 Infection Outcomes and Mutations Associated With B-Cell Deficiency: A Case Report. | Case Rep Infect Dis | 2026 | https://conductscience.org/library/papers/42787905 | PubMed |
| 42726800 | Transdermal 17β-Estradiol for the Treatment of COVID-19: Protocol of an Early Terminated Phase 2 Randomized Controlled Trial. | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/42726800 | PubMed |
| 42715192 | Outcomes of immunocompromised and non-immunocompromised patients in the ICU diverge late in the pandemic. | PLoS One | 2026 | https://conductscience.org/library/papers/42715192 | PubMed |
| 42141325 | Death and ICU Admission Associated with Sars-Cov-2 Variants in Immunocompromised Hospitalised Individuals: A National Observational Study. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/42141325 | PubMed |
| 42100898 | Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project. | J Infect Dis | 2026 | https://conductscience.org/library/papers/42100898 | PubMed |
| 42030071 | Broadly neutralizing monoclonal antibodies derived from mRNA LNP immunization exhibit potent neutralizing ability against JN.1, KP.3.1.1 and XEC new Omicron variants. | J Gen Virol | 2026 | https://conductscience.org/library/papers/42030071 | PubMed |
| 41869987 | Risk of SARS-CoV-2 Infection and Hospitalisation in Immunocompromised Children: A Population-Based Cohort Study in Italy and Norway. | Acta Paediatr | 2026 | https://conductscience.org/library/papers/41869987 | PubMed |
| 41801614 | Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study. | J Epidemiol Glob Health | 2026 | https://conductscience.org/library/papers/41801614 | PubMed |
| 41729838 | A dynamic model of COVID-19 infection quantifies the impact of preventive interventions on the infection of severely immunocompromised subjects in the United Kingdom. | PLoS One | 2026 | https://conductscience.org/library/papers/41729838 | PubMed |
| 41603290 | Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variants. | Protein Sci | 2026 | https://conductscience.org/library/papers/41603290 | PubMed |
| 41526596 | Adoptive T-cell therapies for persistent COVID-19 in immunocompromised patients: Comparison of IFN-γ virus-specific T-cell therapy and CD45RA+ T-cell depleted donor lymphocyte infusion. | Geroscience | 2026 | https://conductscience.org/library/papers/41526596 | PubMed |
| 41287034 | Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes. | Pneumonia (Nathan) | 2025 | https://conductscience.org/library/papers/41287034 | PubMed |
| 41283262 | Exit Meta-Analysis on the Effect of HIV on COVID-19 Mortality, Hospitalization, and ICU Admission. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/41283262 | PubMed |
| 41157586 | SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes. | Viruses | 2025 | https://conductscience.org/library/papers/41157586 | PubMed |
| 41136410 | Acute SARS-CoV-2 infection. | Nat Rev Dis Primers | 2025 | https://conductscience.org/library/papers/41136410 | PubMed |
| 41133078 | Characteristics and Outcomes of Immunocompromised Patients With COVID-19 Infection Admitted to an Intensive Care Unit: A Retrospective Cohort Study. | Cureus | 2025 | https://conductscience.org/library/papers/41133078 | PubMed |
| 40868058 | Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868058 | PubMed |
| 40866469 | Tenofovir attenuates cytokine storm and bronchiolar damage in a mouse model of bleomycin-induced acute lung injury. | Sci Rep | 2025 | https://conductscience.org/library/papers/40866469 | PubMed |
| 40843708 | Multiplex Targeted Proteomic Analysis of Cytokine Ratios for ICU Mortality in Severe COVID-19. | Proteomes | 2025 | https://conductscience.org/library/papers/40843708 | PubMed |
| 40715278 | Corticosteroids in immunocompromised ICU patients with severe COVID-19: a multicenter retrospective study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40715278 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| ISRCTN | ISRCTN07774040 |
Source ISRCTN
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36719907
GET https://conductscience.org/api/papers/v1/36719907/references?page=2